Compare WGS & CENT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WGS | CENT |
|---|---|---|
| Founded | 2017 | 1955 |
| Country | United States | United States |
| Employees | 1300 | 6000 |
| Industry | Retail: Computer Software & Peripheral Equipment | Consumer Specialties |
| Sector | Technology | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.2B |
| IPO Year | N/A | N/A |
| Metric | WGS | CENT |
|---|---|---|
| Price | $65.76 | $36.91 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 1 |
| Target Price | ★ $130.71 | $50.00 |
| AVG Volume (30 Days) | ★ 628.4K | 92.3K |
| Earning Date | 04-29-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $29.98 | $1.60 |
| Revenue Next Year | $25.92 | $2.04 |
| P/E Ratio | $1,251.58 | ★ $15.73 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $55.17 | $28.77 |
| 52 Week High | $170.87 | $41.25 |
| Indicator | WGS | CENT |
|---|---|---|
| Relative Strength Index (RSI) | 40.44 | 51.84 |
| Support Level | $61.55 | $35.07 |
| Resistance Level | $95.75 | $37.86 |
| Average True Range (ATR) | 4.01 | 0.96 |
| MACD | 0.81 | -0.03 |
| Stochastic Oscillator | 57.85 | 65.92 |
GeneDx Holdings Corp focuses on genomics, creating the foundation for providing genomic information at scale and pioneering exome and genome sequencing for rare and ultra-rare genetic pediatric disorders. The company believes exome and genome testing will become the standard for diagnosing genetic disease, with the potential to transform healthcare from reactive to proactive. It aims to advance precision medicine by offering genetic diagnoses at the earliest moments, driving improved outcomes, and fueling discovery with genomic intelligence. Its operating segment mainly provides pediatric and rare disease diagnostics, focusing on whole exome and genome sequencing and, to a lesser extent, data and information services.
Central Garden & Pet Co offers solutions that support healthier pets, greener lawns, and thriving gardens. Its products include dog and cat treats, chews, toys, beds, containment, grooming supplies, aquatics, small animal and bird supplies, equine and livestock products, insect control solutions, grass seed, wild bird feed, fertilizers, pest controls, live plants, and packet seeds, sold under brands such as Aqueon, Nylabone, Kaytee, Farnam, Pennington, Ferry Morse, Amdro, and Sevin. The company operates through two segments, Pet and Garden, and sells through retailers, independent stores, eCommerce channels, and professional markets. It has sales and distribution operations mainly across the United States, with additional facilities in Canada and Mexico.